Efficacy and security of sustained-release doxazosin in the treatment of lower urinary tract symptoms in elderly patients with benign prostatic hyperplasia
10.3760/cma.j.issn.0254-9026.2013.06.019
- VernacularTitle:多沙唑嗪缓释片改善老年良性前列腺增生患者下尿路症状的观察
- Author:
Xin WANG
;
Ming LIU
;
Xin CHEN
;
Hong MA
;
Ben WAN
;
Jianye WANG
- Publication Type:Journal Article
- Keywords:
Doxazosin;
Prostatic hyperplasia
- From:
Chinese Journal of Geriatrics
2013;(6):636-639
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of doxazosin gastrointestinal therapeutic system (DOX GITS) in the treatment of lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH).Methods A total of 4063 BPH patients aged ≥60 years from 16 regions and 86 hospitals were enrolled in this study.Patients were divided into 4 groups according to the previous medication:group 1 (treated with α1 receptor blocker but non-doxazosin),group 2 (treated with drugs without α1 receptor blocker),group 3 (without treatment),group 4 (treated with α1 receptor blocker but non-doxazosin and other drugs for BPH).Patients received DOX GITS with a flexible-dosage for 4 weeks.International prostate symptom score (IPSS),quality of life (QOL),maximum urine flow rate (Qmax) and adverse effects were assessed.Results After 4 weeks of the treatment,lower urinary tract symptoms were significantly improved in the 4 group.IPSS in the 4 groups were decreased to (12.3±4.6) scores,(12.2±4.6) scores,(10.9±4.5) scores and (9.9±4.4) scores successively.QOL in the 4 groups were improved to (2.8±0.9) scores,(2.8 ±1.0) scores,(2.5±0.9) scores and (2.4±0.9) scores successively.Qma x in the 4 groups were increased to (16.4±4.5) ml/s,(15.0±4.7) ml/s,(15.3±4.8) ml/s and (16.7±5.7) ml/s qsuccessively.There were significant differences in IPSS,QOL and Qmax of the 4 groups between before and after the treatment (P<0.001).Adverse events were reported in 64% of patients.The most common adverse events were dizziness of 43 cases (1.06%),postural hypotension of 10 cases (0.25%) and hypotension of 8 cases (0.20%).Conclusions DOX GITS can significantly improveLUTS and quality of life in BPH patients with a good tolerance and compliance.